CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 98 filers reported holding CYTOSORBENTS CORP in Q1 2021. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $505,000 | +7.4% | 62,187 | 0.0% | 0.03% | +6.5% |
Q2 2021 | $470,000 | -13.0% | 62,187 | 0.0% | 0.03% | -20.5% |
Q1 2021 | $540,000 | +8.9% | 62,187 | 0.0% | 0.04% | -11.4% |
Q4 2020 | $496,000 | 0.0% | 62,187 | 0.0% | 0.04% | -18.5% |
Q3 2020 | $496,000 | -19.5% | 62,187 | 0.0% | 0.05% | -29.9% |
Q2 2020 | $616,000 | +28.1% | 62,187 | 0.0% | 0.08% | +8.5% |
Q1 2020 | $481,000 | +100.4% | 62,187 | -0.1% | 0.07% | +129.0% |
Q4 2019 | $240,000 | -23.3% | 62,279 | 0.0% | 0.03% | -31.1% |
Q3 2019 | $313,000 | -23.7% | 62,279 | +0.3% | 0.04% | -30.8% |
Q2 2019 | $410,000 | -12.8% | 62,079 | 0.0% | 0.06% | -18.8% |
Q1 2019 | $470,000 | -6.4% | 62,079 | 0.0% | 0.08% | -17.5% |
Q4 2018 | $502,000 | -37.3% | 62,079 | 0.0% | 0.10% | -34.0% |
Q3 2018 | $801,000 | +13.1% | 62,079 | 0.0% | 0.15% | +5.8% |
Q2 2018 | $708,000 | +61.6% | 62,079 | 0.0% | 0.14% | +40.4% |
Q1 2018 | $438,000 | +14.4% | 62,079 | +5.4% | 0.10% | +1.0% |
Q4 2017 | $383,000 | +4.9% | 58,899 | 0.0% | 0.10% | -9.3% |
Q3 2017 | $365,000 | – | 58,899 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
Avenir Corp | 76,390 | $617,000 | 0.08% |
Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |